Infection & Immunity
Vision statement
Research is directed towards the design, development and evaluation of antimicrobial agents. It encompasses the study of microbial pathogenicity and the determinants of antimicrobial resistance. Studies concentrate on particular challenges of pathogens such as anthrax spores, prions, MRSA and viruses, in recognition of the significant health gains to be made in resolving infections by these organisms. For example, and with the aid of molecular modelling, major advances have been made in antiviral design. Furthermore, alternative approaches to conventional chemotherapeutic agents feature strongly in this theme's research, exploiting both host immune response and bacteriophage as protection against infection.
Current Projects in Infection & Immunity
Lovleen Tina Joshi, a first year PhD student, wins the best poster prize
Grant Awards to WSP staff by research theme, 01/2001 to 04/2007 - Infection and Immunity (£3.25m)
Funding sources for Infection & Immunity
- ASP Biocides
- Biofusion
- Biotechnology & Biological Sciences Research Council
- Cardiff Partnership Fund
- Cardiff Protides Ltd
- Cardiff & Vale NHS Trust
- Ciba Speciality Chemicals Inc
- Commission of European Communities
- Department of Health
- F. Hoffman-La Roche Ltd
- Fermavir Research Inc
- Henderson Morley PLC
- Medical Research Council
- Reckitt & Coleman Products
- Royal Society
- Society for Applied Microbiology
- Steris Ltd
- VETXX
- Wellcome Trust
- Welsh Office for Research & Development